Revance Therapeutics Inc. buy michaelkr
Start price
09.12.24
/
50%
€3.66
Target price
09.12.25
-
Performance (%)
-19.67%
End price
22.12.24
€2.94
Summary
This prediction ended on 22.12.24 with a price of €2.94. The prediction for Revance Therapeutics Inc. disappointed with a performance of -19.67%. michaelkr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 2,59 % | 2,69 % | 6,41 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % | 20,65 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % | 46,17 % |
| iShares S&P 500 | -0,37 % | -0,83 % | 18,02 % |
Comments by michaelkr for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Buy Revance Therapeutics Inc.